Meet Our Scientific Advisory Board
Our Scientific Advisory Board brings decades of experience in dermatology, skin cancer, genomics, and biotech innovation to help us redefine the way we test and treat skin cancer.
Neal Bhatia, M.D.
Dr. Neal Bhatia is a board-certified dermatologist. He serves as Director of Clinical Dermatology at Therapeutics Clinical Research and is an Associate Clinical Professor at Harbor-UCLA Medical Center. He is chief medical editor for Practical Dermatology. He has a background in immunology and has interests in mechanisms of therapy, skin cancer, and medical dermatology. In addition to teaching at medical conferences, he sits on several editorial boards and is an active teacher for dermatologists, industry, and patients. Dr. Bhatia will begin his term as Vice President-elect of the AAD in 2020 and will serve his one year term as Vice President starting in March 2021. Dr. Bhatia receives compensation from DermTech as a scientific/medical advisor.
Brook Brouha, M.D., Ph.D.
Dr. Brook Brouha is a board-certified dermatologist and dermatopathologist. Dr. Brouha completed his dermatology residency training at the University of California at San Diego and dermatopathology fellowship at the University of Texas Southwestern Medical Center. He received his Ph.D. in genetics from the University of Pennsylvania and his medical degree from the University of Pennsylvania School of Medicine. Dr. Brouha is a fellow of the American Academy of Dermatology, a member of the prestigious Noah Worcester Dermatological Society and has served on the board of the Pacific Dermatology Association. Dr. Brouha has also published numerous articles in peer reviewed professional journals. Dr. Brouha receives compensation from DermTech as a scientific/medical advisor.
Clay Cockerell, M.D.
Dr. Cockerell is a board-certified dermatologist and dermatopathologist and a past president of the American Academy of Dermatology. He is the founder and medical director of Cockerell Dermatopathology and a professor in both the Department of Dermatology and the Department of Pathology at UT Southwestern Medical Center where he also serves as the director of the dermatopathology division. He specializes in skin cancer, such as melanoma, at the Harold C. Simmons Comprehensive Cancer Center. Dr. Cockerell receives compensation from DermTech as a scientific/medical advisor.
Laura Ferris, M.D., Ph.D.
Laura Korb Ferris, M.D., Ph.D., is an Associate Professor and Director of Clinical Trials at the University of Pittsburgh Department of Dermatology. She is a member of the University of Pittsburgh Cancer Institute melanoma program, where she directs the pigmented lesions clinic. Dr. Ferris has been an investigator on several clinical trials evaluating technologies and assays for melanoma early detection and predictors of outcome in patients with melanoma. Her research, which is primarily focused on melanoma epidemiology, screening, and early detection has been widely published in the peer-reviewed literature. Dr. Ferris received her Ph.D. in immunology from The Johns Hopkins School of Medicine and her M.D. from The University of Maryland and she completed her residency in dermatology and fellowship in cutaneous oncology at the University of Pittsburgh. Dr. Ferris receives compensation from DermTech as a scientific/medical advisor.
Mark Kaufman, M.D.
Dr. Kaufman is a board-certified dermatologist. He serves as an Associate Clinical Professor of Dermatology at the Mount Sinai School of Medicine where he teaches residents-in-training dermatologic surgery. Dr. Kaufmann is a contributing editor to Practical Dermatology and serves on the editorial boards of The Journal of Drugs in Dermatology, as well as The Journal of Clinical and Aesthetic Dermatology. Dr. Kaufmann currently serves on the Board of Directors of the American Academy of Dermatology. He is also chair of the academy’s Resource Based Relative Value Scale (RBRVS) committee, as well as a member of the Innovations in Payment and Delivery Work group. Dr. Kaufmann will begin his term as President-elect of the AAD in 2020 and will serve his one year term as President starting in March 2021. Dr. Kaufman receives compensation from DermTech as a scientific/medical advisor.
Ronald Moy, M.D.
Dr. Ronald Moy is a board-certified dermatologist and a diplomate of the American Board of Dermatology. He is a leader in the field of dermatology as a past President of the American Academy of Dermatology, Pacific Dermatologic Association and American Society for Dermatologic Surgery and as Vice President of the Skin Cancer Foundation. Dr. Moy completed his dermatology residency training at UCLA and his Facial Cosmetic and Mohs Micrographic Surgery Fellowship training at the University of Pittsburgh Center for Health Services. He is a former professor at the David Geffen School of Medicine at UCLA, former Co-Chief of the UCLA division of Dermatology and former Chief of Dermatologic Surgery. He has served as president of the Los Angeles County Medical Association, Bay District and Editor-in-Chief of the Dermatologic Surgery Journal. Dr. Moy receives compensation from DermTech as a scientific/medical advisor.
Gary Peck, M.D.
Dr. Gary Peck is a board-certified dermatologist that began his career at the National Institutes of Health in the Dermatology Branch of the National Cancer Institute. He is a recipient of the Discovery Award of the Dermatology Foundation, the highest award in Dermatology in recognition of his discovery of isotretinoin for the treatment of severe, recalcitrant nodulocystic acne and other disorders, including the prevention of basal cell carcinomas. Dr. Peck founded and served as director of the Melanoma Center at the Washington Hospital Cancer Institute, the first center of its kind in the nation’s capital. The Melanoma Center is a multi-specialty clinic that has accrued over 2,000 cases of melanoma and screens hundreds of high-risk patients for the development of melanoma. Dr. Peck received his MD from the University of Michigan Medical School in Ann Arbor, Michigan. He completed his dermatology residency training at the University of Chicago Hospitals. Dr. Peck has published over 150 original articles, book chapters, and research abstracts. Dr. Peck receives compensation from DermTech as a scientific/medical advisor.
Darrel Rigel, M.D.
Dr. Darrel Rigel is a Clinical Professor of Dermatology at New York University Medical Center. He received his BS and MBA from MIT and his MD degree from George Washington University. He attended Cornell University Medical Center for his internship in Internal Medicine, and completed his training at NYU where he was Resident, Chief Resident, NIH Training Fellow and Dermatology Surgery Fellow. Dr. Rigel has served as President of the American Academy of Dermatology (1999) and for nine years as a Director of the American Board of Dermatology. He is a Past President of the American Society for Dermatologic Surgery and the American Dermatological Association. Dr. Rigel has also received numerous honors including the American Cancer Society’s National Honor Citation for Skin Cancer Programs and Presidential Citations from the American Academy of Dermatology and American Society for Dermatologic Surgery for public education programs in skin cancer. Dr. Rigel receives compensation from DermTech as a scientific/medical advisor.
Ted Rosen, M.D.
Dr. Rosen is a board-certified dermatologist. He currently serves as Professor of Dermatology at Baylor College of Medicine and Chief of Dermatology at the Houston Veterans Affairs Medical Center. Dr. Rosen is a past Vice President of the American Academy of Dermatology and has served on their Board of Directors. He is the recipient of the 2017 AAD Thomas Pearson Memorial Award for career excellence in educational activities. Dr. Rosen serves on the editorial boards of Cutis, Dermatology Online Journal, International Journal of Dermatology, Skin Therapy Letter, and UpToDate, and is the North American Editor of Global Skin Atlas. He has published over 285 peer-reviewed journal articles, 25 textbook chapters, and four medical textbooks. Dr. Rosen receives compensation from DermTech as a scientific/medical advisor.
Daniel Siegel, M.D.
Dr. Daniel M. Siegel is a Clinical Professor of Dermatology and former Director of the Procedural Dermatology Fellowship at SUNY Downstate. He has served as president of the AAD (2012) and is a past member of both the Academy’s Board of Directors and Coding and Reimbursement Task Force. He is a diplomate of the American Board of Dermatology and the American Board of Laser Surgery and is a fellow of the American Society for Dermatologic Surgery (ASDS), the American Academy of Dermatology (AAD), the American College of Mohs Surgery and the American Society of Mohs Surgery. Dr. Siegel earned his medical degree from Albany Medical College in Albany, NY. He completed his residency in dermatology at the University of Texas Health Sciences Center at Dallas and his fellowship at the Baylor College of Medicine in Houston. Dr. Siegel also earned a Master of Science degree in management and policy from Stony Brook University in Stony Brook, NY. Dr. Siegel receives compensation from DermTech as a scientific/medical advisor.
Maral Skelsey, M.D.
Dr. Maral Skelsey is the Director of the Dermatologic Surgery Center of Washington and Clinical Professor and Director of the Dermatologic Surgery at Georgetown University Medical Center in Washington, D.C. Dr. Skelsey received her medical degree from Washington School of Medicine in St. Louis, MO where she also completed her dermatology residency and served as Chief Resident. She completed her fellowship through the American College of Mohs Surgery at the University of Alabama in Birmingham. Dr. Skelsey is a fellow of the American Academy of Dermatology (AAD). She has published numerous articles in peer review professional journals. She serves as an officer of the Washington D.C. Dermatologic Society and is a Fellow of the American Society of Laser Medicine and Surgery, the American Society of Dermatologic Surgery and the American College of Mohs Surgery. Dr. Skelsey receives compensation from DermTech as a scientific/medical advisor.